文献速递眼底病与葡萄膜炎

增生性糖尿病视网膜病变继发玻璃体积血的早期与延迟玻璃体切除术比较

Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy.
PubMed 文献 · Am J Ophthalmol · 2024-10-28

回顾性对比研究纳入2014年12月至2016年12月在Moorfields眼科医院因增生性糖尿病视网膜病变首次玻璃体积血行玻璃体切除术的178眼,早期组48眼、延迟组130眼。12个月时早期组最佳矫正视力显著优于延迟组(0.40 logMAR vs 0.67 logMAR,P=0.02),且威胁视力并发症更少(P=0.005)。结论支持早期手术干预,但作者指出需随机临床试验验证。

要点

  • 早期玻璃体切除术组12个月最佳矫正视力0.40 logMAR,优于延迟组0.67 logMAR(P=0.02)。
  • 超声或OCT无玻璃体后脱离证据者,早期组与延迟组视力差异更明显(0.3 logMAR vs 0.7 logMAR,P=0.001)。
  • 早期组威胁视力并发症更少(P=0.005),初始视力、早期手术及术前未行全视网膜光凝为更好视力预后的显著预测因素。

核心结论

  • 早期玻璃体切除术显著改善增生性糖尿病视网膜病变继发玻璃体积血患者的视力结局并减少严重并发症,但需随机临床试验验证。

研究设计与样本

  • 回顾性、对比性、干预性研究,纳入2014年12月至2016年12月在Moorfields眼科医院因增生性糖尿病视网膜病变新发玻璃体积血行玻璃体切除术的连续患者,共178眼(早期组48眼,延迟组130眼)。

主要发现

  • 术前平均(SD)等待周数早期组为3.36(SD 1.6)周,延迟组为22.56(SD 17.23)周(P<.0001)。
  • 术前基线最佳矫正视力两组相似(P=.08)。
  • 12个月时早期组最佳矫正视力显著优于延迟组(0.40 logMAR vs 0.67 logMAR;P=.02)。
  • 超声或OCT无玻璃体后脱离证据者,早期组与延迟组视力差异更明显(0.3 logMAR vs 0.7 logMAR;P=.001)。
  • 早期组威胁视力并发症更少(P=.005);多变量逻辑回归显示初始最佳矫正视力、早期玻璃体切除术及术前未行全视网膜光凝是更好视力结局的显著预测因素。

关键数值与推荐

  • 早期玻璃体切除术定义为≤6周,延迟玻璃体切除术定义为>6周。

临床怎么用

  • 原文结论认为这些发现支持早期手术干预以改善此类患者的长期视力预后,但作者同时指出需随机临床试验验证。

局限性

  • 原文结论指出需随机临床试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the clinical outcomes of early pars plana vitrectomy (PPV) versus delayed PPV in patients with first episode of vitreous hemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR). DESIGN: Retrospective, comparative, interventional study. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: Consecutive patients with type 1 or II diabetes diagnosed with new onset VH secondary to PDR who underwent PPV at Moorfields Eye Hospital between December 2014 and December 2016. Exclusions were prior vitrectomy, iris neovascularization, neovascular glaucoma, macular edema, or presence of tractional/rhegmatogenous retinal detachment. METHODS, INTERVENTION, OR TESTING: Patients were divided into two groups based on the timing of their surgery: early PPV (≤6 weeks) and delayed PPV (>6 weeks). Demographic and clinical features, including best-corrected visual acuity (BCVA), expressed in logMAR at baseline and 12 months were collected. Statistical analyses, including propensity score matching, were performed using Python 3.10, Scikit-learn, Pandas, and GraphPad Prism 10. MAIN OUTCOME MEASURES: BCVA at 12 months postoperatively, reoperation rates, and severity of complications. RESULTS: A total of 178 eyes were analyzed (48 early PPV, 130 delayed PPV). The mean (SD) number of weeks before surgery was 3.36 (SD 1.6) for the early PPV group and 22.56 (SD 17.23) for the delayed PPV group (P < .0001). Baseline BCVA prior to PPV was similar between groups (P = .08). At 12 months, the early PPV group had significantly better BCVA (0.40 logMAR vs 0.67 logMAR; P = .02). Patients without evidence of posterior vitreous detachment on ultrasound or OCT showed more pronounced differences (0.3 logMAR vs 0.7 logMAR; P = .001). The early PPV group had fewer sight-threatening complications (P = .005). Multivariable logistic regression identified initial BCVA, early PPV, and absence of preoperative panretinal photocoagulation as significant predictors of better visual outcomes. CONCLUSIONS: Early PPV significantly improves visual outcomes and reduces severe complications in patients with VH secondary to PDR. These findings support the benefits of early surgical intervention to enhance long-term visual prognosis in these patients. However, a randomized clinical trial is warranted.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Anguita R, Ferro Desideri L, Schwember P, et al. Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy. Am J Ophthalmol. 2024. PMID: 39471907. doi:10.1016/j.ajo.2024.10.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。